BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Genetown

  Boston Scientific Corporation Welcomes Publication of HORIZONS AMI Trial Results in The New England Journal of Medicine

  May 7, 2009

   · 

  6 min read
• Business

  DUSA Pharmaceuticals Announces First Quarter Financial Results and Corporate Highlights Conference Call

  May 7, 2009

   · 

  1 min read
• Biotech Bay

  PEAK Surgical, Inc. Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery

  May 7, 2009

   · 

  5 min read
• Business

  Agilent Technologies Inc. Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity

  May 7, 2009

   · 

  1 min read
• Business

  PharmAthene, Inc. to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

  May 7, 2009

   · 

  1 min read
• Business

  Savient Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results

  May 7, 2009

   · 

  8 min read
• FDA

  Vanda Pharmaceuticals, Inc. Surges on Fanapt FDA Approval; Stock Up +625.93% at Market Close

  May 7, 2009

   · 

  2 min read
• Drug Development

  Amsterdam Molecular Therapeutics (AMT) Starts Preregistration Trial for Glybera(TM)

  May 7, 2009

   · 

  3 min read
• Drug Development

  Analyses Of Phase 3 Blood Pressure Data For NicOx SA’s Naproxcinod Presented At American Society of Hypertension

  May 7, 2009

   · 

  4 min read
• Business

  Cell Therapeutics, Inc. Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009

  May 7, 2009

   · 

  4 min read